The Artificial Pancreas in 2016: A Digital Treatment Ecosystem for Diabetes.
作者信息
Kovatchev Boris, Tamborlane William V, Cefalu William T, Cobelli Claudio
机构信息
Center for Diabetes Technology, University of Virginia, Charlottesville, VA.
Division of Pediatric Endocrinology, Department of Pediatrics, Yale School of Medicine, New Haven, CT.
出版信息
Diabetes Care. 2016 Jul;39(7):1123-6. doi: 10.2337/dc16-0824.
Abstract
摘要
相似文献
1
The Artificial Pancreas in 2016: A Digital Treatment Ecosystem for Diabetes.2016年的人工胰腺：糖尿病的数字治疗生态系统。
Diabetes Care. 2016 Jul;39(7):1123-6. doi: 10.2337/dc16-0824.
2
Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.双激素人工胰腺、单激素人工胰腺或传统胰岛素泵治疗在儿童和青少年 1 型糖尿病患者中的门诊过夜血糖控制：一项开放标签、随机对照试验。
Lancet Diabetes Endocrinol. 2015 Aug;3(8):595-604. doi: 10.1016/S2213-8587(15)00141-2. Epub 2015 Jun 8.
3
Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.双激素人工胰腺、单激素人工胰腺与常规胰岛素泵治疗对 1 型糖尿病患者血糖控制的比较：一项开放标签随机对照交叉试验。
Lancet Diabetes Endocrinol. 2015 Jan;3(1):17-26. doi: 10.1016/S2213-8587(14)70226-8. Epub 2014 Nov 27.
4
Current status and issues of the artificial pancreas: abridged English translation of a special issue in Japanese.人工胰腺的现状与问题：日文特刊的英文节译
J Artif Organs. 2018 Jun;21(2):132-137. doi: 10.1007/s10047-018-1019-4. Epub 2018 Jan 22.
5
Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover trial.单激素和双激素人工胰腺对1型糖尿病成年患者持续运动和间歇运动的疗效：随机对照交叉试验
Diabetologia. 2016 Dec;59(12):2561-2571. doi: 10.1007/s00125-016-4107-0. Epub 2016 Oct 4.
6
Performance and safety of an integrated bihormonal artificial pancreas for fully automated glucose control at home.一种用于家庭全自动血糖控制的集成双激素人工胰腺的性能与安全性。
Diabetes Obes Metab. 2016 Jul;18(7):671-7. doi: 10.1111/dom.12663. Epub 2016 Apr 25.
7
Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes.用于1型糖尿病患者夜间血糖控制的单激素和双激素人工胰腺
J Clin Endocrinol Metab. 2016 Jan;101(1):214-23. doi: 10.1210/jc.2015-3003. Epub 2015 Nov 2.
8
Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial.夜间低血糖感知障碍的 1 型糖尿病患者应用双重和单激素人工胰腺控制血糖：一项随机对照试验。
Diabetes Technol Ther. 2018 Mar;20(3):189-196. doi: 10.1089/dia.2017.0353. Epub 2018 Feb 2.
9
Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials.人工胰腺系统对 1 型糖尿病患者血糖控制的影响：一项门诊随机对照试验的系统评价和荟萃分析。
Lancet Diabetes Endocrinol. 2017 Jul;5(7):501-512. doi: 10.1016/S2213-8587(17)30167-5. Epub 2017 May 19.
10
An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.用于1型糖尿病患者自动血糖控制的人工胰腺。
Ther Deliv. 2015;6(5):609-19. doi: 10.4155/tde.15.12.
引用本文的文献
1
Artificial Pancreas: The First 20 Years.人工胰腺：头20年
J Diabetes Sci Technol. 2025 Jul;19(4):875-882. doi: 10.1177/19322968251330920. Epub 2025 Jul 1.
2
Developing the UVA/Padova Type 1 Diabetes Simulator: Modeling, Validation, Refinements, and Utility.开发 UVA/Padova 1 型糖尿病模拟器：建模、验证、改进和应用。
J Diabetes Sci Technol. 2023 Nov;17(6):1493-1505. doi: 10.1177/19322968231195081. Epub 2023 Sep 25.
3
Glucose Prediction under Variable-Length Time-Stamped Daily Events: A Seasonal Stochastic Local Modeling Framework.可变时长时间戳每日事件下的葡萄糖预测：一种季节性随机局部建模框架
Sensors (Basel). 2021 May 4;21(9):3188. doi: 10.3390/s21093188.
4
Replay Simulations with Personalized Metabolic Model for Treatment Design and Evaluation in Type 1 Diabetes.利用个性化代谢模型进行 1 型糖尿病治疗设计和评估的回放模拟。
J Diabetes Sci Technol. 2021 Nov;15(6):1326-1336. doi: 10.1177/1932296820973193. Epub 2020 Nov 20.
5
Evening and overnight closed-loop control versus 24/7 continuous closed-loop control for type 1 diabetes: a randomised crossover trial.1 型糖尿病的夜间和夜间闭环控制与 24/7 持续闭环控制的比较：一项随机交叉试验。
Lancet Digit Health. 2020 Feb;2(2):e64-e73. doi: 10.1016/S2589-7500(19)30218-3. Epub 2020 Jan 3.
6
Closed-Loop Control with Unannounced Exercise for Adults with Type 1 Diabetes using the Ensemble Model Predictive Control.使用集成模型预测控制对1型糖尿病成人进行无预告运动的闭环控制
J Process Control. 2019 Aug;80:202-210. doi: 10.1016/j.jprocont.2019.05.017. Epub 2019 Jun 23.
7
Online Glucose Prediction Using Computationally Efficient Sparse Kernel Filtering Algorithms in Type-1 Diabetes.在1型糖尿病中使用计算高效的稀疏核滤波算法进行在线血糖预测
IEEE Trans Control Syst Technol. 2020 Jan;28(1):3-15. doi: 10.1109/tcst.2018.2843785. Epub 2018 Jun 22.
8
Automated closed-loop control of diabetes: the artificial pancreas.糖尿病的自动闭环控制：人工胰腺
Bioelectron Med. 2018 Nov 7;4:14. doi: 10.1186/s42234-018-0015-6. eCollection 2018.
9
A machine-learning approach to predict postprandial hypoglycemia.一种预测餐后低血糖的机器学习方法。
BMC Med Inform Decis Mak. 2019 Nov 6;19(1):210. doi: 10.1186/s12911-019-0943-4.
10
In Silico Analysis of an Exercise-Safe Artificial Pancreas With Multistage Model Predictive Control and Insulin Safety System.具有多阶段模型预测控制和胰岛素安全系统的运动安全型人工胰腺的计算机模拟分析
J Diabetes Sci Technol. 2019 Nov;13(6):1054-1064. doi: 10.1177/1932296819879084.
本文引用的文献
1
Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report.人工胰腺临床试验的结局指标：一份共识报告。
Diabetes Care. 2016 Jul;39(7):1175-9. doi: 10.2337/dc15-2716.
2
Design Considerations for Artificial Pancreas Pivotal Studies.人工胰腺关键研究的设计考虑因素。
Diabetes Care. 2016 Jul;39(7):1161-7. doi: 10.2337/dc15-2449.
3
Randomized Crossover Comparison of Personalized MPC and PID Control Algorithms for the Artificial Pancreas.人工胰腺个性化模型预测控制（MPC）和比例积分微分（PID）控制算法的随机交叉比较
Diabetes Care. 2016 Jul;39(7):1135-42. doi: 10.2337/dc15-2344. Epub 2016 Jun 11.
4
Randomized Summer Camp Crossover Trial in 5- to 9-Year-Old Children: Outpatient Wearable Artificial Pancreas Is Feasible and Safe.5 至 9 岁儿童随机夏令营交叉试验：门诊使用可穿戴式人工胰腺是可行且安全的。
Diabetes Care. 2016 Jul;39(7):1180-5. doi: 10.2337/dc15-2815. Epub 2016 May 10.
5
Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide.在闭环胰岛素输注期间以胰岛素节省方式减轻与进餐相关的血糖波动：辅助使用普兰林肽和利拉鲁肽的有益效果。
Diabetes Care. 2016 Jul;39(7):1127-34. doi: 10.2337/dc16-0089. Epub 2016 May 5.
6
Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home.1 型糖尿病患者在自由生活条件下的日夜闭环血糖控制：与之前在家中进行的夜间可行性研究相比，为期 1 个月的单臂经验结果。
Diabetes Care. 2016 Jul;39(7):1151-60. doi: 10.2337/dc16-0008. Epub 2016 May 5.
7
Multinational Home Use of Closed-Loop Control Is Safe and Effective.跨国居家使用闭环控制系统是安全有效的。
Diabetes Care. 2016 Jul;39(7):1143-50. doi: 10.2337/dc15-2468. Epub 2016 Apr 13.
8
Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical Trial.1型糖尿病青少年的昼夜混合闭环胰岛素给药：一项自由生活的随机临床试验。
Diabetes Care. 2016 Jul;39(7):1168-74. doi: 10.2337/dc15-2078. Epub 2016 Jan 6.
9
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.2 个月的 1 型糖尿病患者在自由生活条件下的夜间和夜间闭环血糖控制：一项随机交叉试验。
Lancet Diabetes Endocrinol. 2015 Dec;3(12):939-47. doi: 10.1016/S2213-8587(15)00335-6. Epub 2015 Sep 30.
10
Home Use of an Artificial Beta Cell in Type 1 Diabetes.1型糖尿病患者在家中使用人工β细胞
N Engl J Med. 2015 Nov 26;373(22):2129-2140. doi: 10.1056/NEJMoa1509351. Epub 2015 Sep 17.
Zotero 插件